Beyond Air

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Fortinet_logo

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

CRVS

CYRX

DZSI

FTNT

LITM

LUMN

MYND

NVRO

PRCH

SCPX

STEM

SWIM

TLIS

UPST

VBIV

XAIR

ZCMD

Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Biotech

Earnings

Earnings Beats

Penny Stocks

Small Cap

Analyst Ratings

General

Alterity Therapeutics Limited - American Depositary Shares

ATHE

CGEN

TRDA

Shares of Alterity Therapeutics (NASDAQ: ATHE) were up 7.8% on Jul 17 after the company announced positive interim data from the phase II ATH434-202 study evaluating its lead pipeline candidate ATH434 for treating patients with multiple system atrophy, a rare neurodegenerative disease.

Alterity Up on Interim Data From Advance MSA Study

NRIX

Beyond Air, Inc. (NASDAQ: XAIR) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.67 per share a year ago. These figures are adjusted for non-recurring items.

Beyond Air, Inc. Reports Q4 Loss, Misses Revenue Estimates

Beyond Air Inc

Press Releases

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Health Care

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Financing

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer's Disease and Reinforcing Platform's Strength Across Neurological Disorders

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Management

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Legal

Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections  Using gaseous Nitric Oxide (gNO)

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Apyx Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Biomerica

BioSig Technologies

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Daxor

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Iridex

INVO Fertility

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

NeuroMetrix

Nexalin Technology

PAVmed

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Zynex

Roth MKM

Piper Sandler

Truist Securities

Oppenheimer

Ladenburg Thalmann

Comments

Beyond Air

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell